Search Count: 94
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQT |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.99 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EU2 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, EQZ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESQ |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ER8 |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.73 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ERK |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.94 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESK |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESW |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, ESN |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, F3Z |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.86 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EVK |
 |
Fragment-Based Discovery Of A Highly Potent, Orally Bioavailable Inhibitor Which Modulates The Phosphorylation And Catalytic Activity Of Erk1/2
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.82 Å Release Date: 2018-05-30 Classification: SIGNALING PROTEIN Ligands: SO4, DMS, EVQ |
 |
Crystal Structure Of Mycobacterium Tuberculosis Crp-Fnr Family Transcription Factor Cmr (Rv1675C)
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2017-12-13 Classification: TRANSCRIPTION Ligands: SO4, CL |
 |
Crystal Structure Of Mycobacterium Tuberculosis Crp-Fnr Family Transcription Factor Cmr (Rv1675C), Truncated Construct
Organism: Mycobacterium tuberculosis (strain cdc 1551 / oshkosh)
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2017-12-13 Classification: TRANSCRIPTION Ligands: CL |
 |
Organism: Ricinus communis, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:3.10 Å Release Date: 2016-12-07 Classification: Hydrolase/Immune system Ligands: SO4, CL |
 |
Organism: Ricinus communis, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-12-07 Classification: HYDROLASE/IMMUNE SYSTEM Ligands: PG4, ACY, EDO, CL |
 |
Organism: Ricinus communis, Vicugna pacos
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2016-12-07 Classification: HYDROLASE/IMMUNE SYSTEM Ligands: CL, EDO |